Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12566 Results
3042
Coverage of Selected Behavioral Health Services Among Older Medicare and Medicaid Beneficiaries
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2025
Publication Place: Rockville, MD
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3043
COVID-19
Type: Report
Authors: The Academy for Integrating Behavioral Health & Primary Care
Year: 2021
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
HIT & Telehealth See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3044
COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics
Type: Journal Article
Authors: L. Caton, H. Cheng, H. C. Garneau, T. Fisher, B. Harris-Mills, B. Hurley, S. Newman, M. P. McGovern
Year: 2021
Abstract:

BACKGROUND: With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care. OBJECTIVE: To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19. DESIGN: A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days. PARTICIPANTS: We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey. MAIN MEASURES: The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience. KEY RESULTS: A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care. CONCLUSIONS: Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Policy See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
3045
COVID-19 and opioid use disorder: Expanding treatment access in rural settings
Type: Journal Article
Authors: M. N. Mumba, J. Jaiswal, N. Langner-Smith, G. T. Mugoya, W. Brown, L. L. Davis
Year: 2021
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
3046
COVID-19 and opioid use disorder: Expanding treatment access in rural settings
Type: Journal Article
Authors: Mercy Ngosa Mumba, Jessica Jaiswal, Natalia Langner-Smith, George T. Mugoya, Whitnee Brown, Lori L. Davis
Year: 2021
Topic(s):
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
3048
COVID-19 and practice transformation: Building an office-based opioid treatment program in a family medicine residency practice
Type: Journal Article
Authors: Angela L. Colistra, Yoonjie K. Chung, Sophia Harbove, Yamelisa J. Taveras, Abby Letcher, Nyann Biery, Drew M. Keister
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
HIT & Telehealth See topic collection
3049
COVID-19 and practice transformation: Building an office-based opioid treatment program in a family medicine residency practice
Type: Journal Article
Authors: A. L. Colistra, Y. K. Chung, S. Harbove, Y. J. Taveras, A. Letcher, N. Biery, D. M. Keister
Year: 2023
3050
COVID-19 and treating incarcerated populations for opioid use disorder
Type: Journal Article
Authors: C. J. Donelan, E. Hayes, R. A. Potee, L. Schwartz, E. A. Evans
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
3051
COVID-19 guidance for the field office based opioid treatment
Type: Web Resource
Authors: Ohio Department of Mental Health and Addiction Services
Year: 2020
Abstract:

This information is meant to support providers of office based opioid treatment programs (OBOT) relating to the coronavirus (COVID-19) situation in Ohio.

Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
HIT & Telehealth See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.; This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3054
COVID-19 pandemic led to increase in loneliness around the world
Type: Report
Authors: American Psychological Association
Year: 2022
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3055
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns
Type: Journal Article
Authors: Alexandra M. Mellis, Marc N. Potenza, Jessica N. Hulsey
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
3058
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management
Type: Journal Article
Authors: N. J. Mehtani, J. T. Ristau, H. Snyder, C. Surlyn, J. Eveland, S. Smith-Bernardin, K. R. Knight
Year: 2021
Publication Place: United States
Abstract: BACKGROUND: COVID-19 has exacerbated income inequality, structural racism, and social isolation-issues that drive addiction and have previously manifested in the epidemic of opioid-associated overdose. The co-existence of these epidemics has necessitated care practice changes, including the use of telehealth-based encounters for the diagnosis and management of opioid use disorder (OUD). METHODS: We describe the development of the "Addiction Telehealth Program" (ATP), a telephone-based program to reduce treatment access barriers for people with substance use disorders staying at San Francisco's COVID-19 Isolation and Quarantine (I&Q) sites. Telehealth encounters were documented in the electronic medical record and an internal tracking system for the San Francisco Department of Public Health (SFDPH) COVID-19 Containment Response. Descriptive statistics were collected on a case series of patients initiated on buprenorphine at I&Q sites and indicators of feasibility were measured. RESULTS: Between April 10 and May 25, 2020, ATP consulted on the management of opioid, alcohol, GHB, marijuana, and stimulant use for 59 I&Q site guests. Twelve patients were identified with untreated OUD and newly prescribed buprenorphine. Of these, all were marginally housed, 67% were Black, and 58% had never previously been prescribed medications for OUD. Four self-directed early discharge from I&Q-1 prior to and 3 after initiating buprenorphine. Of the remaining 8 patients, 7 reported continuing to take buprenorphine at the time of I&Q discharge and 1 discontinued. No patients started on buprenorphine sustained significant adverse effects, required emergency care, or experienced overdose. CONCLUSIONS: ATP demonstrates the feasibility of telephone-based management of OUD among a highly marginalized patient population in San Francisco and supports the implementation of similar programs in areas of the U.S. where access to addiction treatment is limited. Legal changes permitting the prescribing of buprenorphine via telehealth without the requirement of an in-person visit should persist beyond the COVID-19 public health emergency.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
3059
Crack cocaine users views regarding treatment with contingency management in Brazil
Type: Journal Article
Authors: A. Q. C. Miguel, C. S. Madruga, V. Simões, R. Yamauchi, C. J. da Silva, R. R. Abdalla, M. McDonell, S. McPherson, J. M. Roll, J. J. Mari, R. R. Laranjeira
Year: 2018
Abstract:

BACKGROUND: Contingency management (CM) has recently shown efficacy in promoting abstinence and retention in treatment among crack cocaine users in Brazil. However, partially because of unawareness and resistance among health care providers, CM has not been widely employed. The objective of this study was to conduct a secondary analysis in order to evaluate how CM participants perceive their treatment experience. METHODS: Twenty-seven crack cocaine users, previously assigned to 12 weeks of CM treatment, were assessed with a structured questionnaire designed to assess their personal opinion of, difficulty in understanding, and acceptance of the CM intervention, as well as their opinion regarding its impact on their treatment responses. RESULTS: Descriptive analyses showed that 92.6% of the participants found it very easy to understand the CM protocol. All participants reported liking their CM experience quite a bit. For the perceived effects of CM on their treatment response, 81.5% of the participants stated that CM helped them considerably, the mean score for the impact of CM on treatment response (out of a maximum of 10) being 9 (SD = 1.5). When asked if they believed CM could help other people with crack cocaine dependence, 92.6% of the participants stated that CM could help such people a lot and 7.4% stated that it could help them a little. CONCLUSIONS: From the perspective of the patients, CM was easily assimilated, easily accepted, and had a direct positive effect on treatment response. These findings provide additional support for the incorporation of CM into substance abuse treatment services in Brazil.

Topic(s):
Opioids & Substance Use See topic collection
3060
CRAFFT as a Substance Use Screening Instrument for Adolescent Psychiatry Admissions
Type: Journal Article
Authors: T. S. Oesterle, M. J. Hitschfeld, T. W. Lineberry, T. D. Schneekloth
Year: 2015
Publication Place: United States
Abstract: BACKGROUND: Adolescent use of alcohol and illicit substances is quite common among pediatric psychiatry inpatients; however, little data exist on substance use screening instruments that can be used to augment thorough psychiatric diagnostic interviews. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings. This is the first study to examine its use in adolescent psychiatric inpatients. METHODS: We performed a chart review of records from adolescents admitted to our inpatient psychiatric unit who completed a CRAFFT screen on admission. We compared CRAFFT scores with other measures of substance use, including urine drug screens and the diagnosis of a substance use disorder at discharge. We also examined measures of depression and suicidality in individuals with elevated CRAFFT scores (>/=2 positive answers out of 6) and compared them with measures in those with normal CRAFFT scores. RESULTS: Elevated CRAFFT scores were correlated with other measures of alcohol and substance use, including the diagnosis of a substance use disorder at discharge (P<0.0001), and laboratory screening for alcohol (P=0.0048) and marijuana (P<0.0001) on admission. Previous suicide attempts (P=0.005) and "psychiatric trauma" (P=0.0027) were also positively associated with elevated CRAFFT scores. CONCLUSIONS: CRAFFT scores in adolescent inpatients were correlated with other measures of substance use, supporting its efficacy as a screening tool in this population. CRAFFT scores were also positively correlated with a history of psychiatric trauma and past suicide attempts, which is consistent with the results of previous studies associating pediatric substance use and traumatic life events with an increased risk of suicide.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection